CCEP
Coca-Cola Europacific Partners PLC (CCEP)
Last Price$86.90.8%
Market Cap$40.3B

CCEP Intrinsic Value

Intrinsic Value of CCEP Overview

Key Highlights:
As of Mar 03, 2025 CCEP Relative Value is $158.6, which is undervalued by 82.5%, compared to current share price of $86.9.
As of Mar 03, 2025 CCEP DCF Value is N/A, which is undervalued by N/A, compared to current share price of $86.9.
Methodology
Price per share, $
Current share price
86.9
DCF value
not available

CCEP Historical Intrinsic Value

Crunching data... Almost there!
Crunching data... Almost there!

CCEP Valuation Metrics

LTM
NTM
1Y Forward
2Y Forward
EV/Revenue
1.3x (as of Mar 03, 2025)
EV/Gross Profit
3.6x (as of Mar 03, 2025)
EV/EBIT
10.4x (as of Mar 03, 2025)
EV/EBITDA
8.5x (as of Mar 03, 2025)
EV/FCF
12.8x (as of Mar 03, 2025)
EV/OCF
9.4x (as of Mar 03, 2025)
P/Revenue
1.0x (as of Mar 03, 2025)
P/Gross Profit
2.8x (as of Mar 03, 2025)
P/EBIT
8.2x (as of Mar 03, 2025)
P/EBITDA
6.7x (as of Mar 03, 2025)
P/FCF
10.0x (as of Mar 03, 2025)
P/OCF
7.4x (as of Mar 03, 2025)
P/E
11.6x (as of Mar 03, 2025)
P/BV
4.3x (as of Mar 03, 2025)
PEG 1Y
0.9x (as of Mar 03, 2025)

CCEP DCF Model

Free Cash Flow to Firm Model
NOPAT Model
Free Cash Flow to Equity Model
Net Income Model
Millions
Billions
Dec'19 ActualDec'20 ActualDec'21 ActualDec'22 ActualDec'23 ActualDec'24 EstimateDec'25 EstimateDec'26 EstimateDec'27 EstimateDec'28 EstimateDec'29 EstimateDec'30 EstimateDec'31 EstimateDec'32 EstimateDec'33 EstimateDec'34 Terminal
% growth
11,982.2
0.8%
10,606.0
(11.5%)
13,763.0
29.8%
17,320.0
25.8%
18,302.0
5.7%
21,334.6
16.6%
22,261.8
4.3%
23,178.6
4.1%
24,107.5
4.0%
25,523.0
5.9%
26,856.9
5.2%
28,087.2
4.6%
29,192.7
3.9%
30,153.3
3.3%
30,950.9
2.6%
31,569.9
2.0%
1,651.2
13.8%
813.0
7.7%
1,773.0
12.9%
2,086.0
12.0%
2,339.0
12.8%
2,455.5
11.5%
2,562.3
11.5%
2,667.8
11.5%
2,774.7
11.5%
2,937.6
11.5%
3,091.1
11.5%
3,232.7
11.5%
3,360.0
11.5%
3,470.5
11.5%
3,562.3
11.5%
3,633.6
11.5%
NOPAT
% effective tax rate
1,237.8
10.3%
582.6
5.5%
1,267.5
9.2%
1,621.3
9.4%
1,772.0
9.7%
1,860.3
8.7%
1,941.2
8.7%
2,021.1
8.7%
2,102.1
8.7%
2,225.5
8.7%
2,341.9
8.7%
2,449.1
8.7%
2,545.5
8.7%
2,629.3
8.7%
2,698.8
8.7%
2,752.8
8.7%
% of revenue
637.1
5.3%
677.3
6.4%
813.2
5.9%
801.3
4.6%
528.0
2.9%
954.4
4.5%
995.8
4.5%
1,036.9
4.5%
1,078.4
4.5%
1,141.7
4.5%
1,201.4
4.5%
1,256.4
4.5%
1,305.9
4.5%
1,348.9
4.5%
1,384.5
4.5%
1,412.2
4.5%
% of revenue
(600.3)
(5.0%)
(408.0)
(3.8%)
(349.0)
(2.5%)
(603.0)
(3.5%)
(672.0)
(3.7%)
(689.0)
(3.2%)
(719.0)
(3.2%)
(748.6)
(3.2%)
(778.6)
(3.2%)
(824.3)
(3.2%)
(867.4)
(3.2%)
(907.1)
(3.2%)
(942.8)
(3.2%)
(973.9)
(3.2%)
(999.6)
(3.2%)
(1,019.6)
(3.2%)
(29.9)
(0.2%)
216.0
2.0%
(393.0)
(2.9%)
427.0
2.5%
232.0
1.3%
62.4
0.3%
65.1
0.3%
67.8
0.3%
70.5
0.3%
74.7
0.3%
78.6
0.3%
82.2
0.3%
85.4
0.3%
88.2
0.3%
90.5
0.3%
92.3
0.3%
Free Cash Flow to Firm (FCFF)
% of revenue
1,244.8
10.4%
1,067.9
10.1%
1,338.7
9.7%
2,246.6
13.0%
1,860.0
10.2%
2,188.1
10.3%
2,283.1
10.3%
2,377.2
10.3%
2,472.4
10.3%
2,617.6
10.3%
2,754.4
10.3%
2,880.6
10.3%
2,994.0
10.3%
3,092.5
10.3%
3,174.3
10.3%
3,237.8
10.3%
% of FCFF used in calculation
Discount period
Discount factor
Discounted FCFF (DFCFF)

CCEP DCF Value

Crunching data... Almost there!

CCEP Earnings Power Value and Enterprise Value

Annual
LTM
Enterprise Value Breakdown
EPV and MIVoG as % of EV

CCEP Reverse DCF

Implied FCF growth
Implied Revenue growth

Reverse DCF Assumptions and Outputs

as of Jun 30, 2024
Long-Term growth rate
2.0%
FX rate
1.1
Last share price
71.6
Implied FCF growth 1-10Y
0.0%

Implied Free Cash Flow growth vs Historical average vs Industry growth

Competing with CCEP Intrinsic Value

Overview
Ratings
Intrinsic Value
Valuation
Growth
Profitability
Health
Capital allocation
Momentum
Earnings
Dividends
Company name
Market Cap
Enterprise Value
Intrinsic Value
DCF Value
Relative value
Ben Graham Revised fair value
Peter Lynch fair value
Earnings Power Value (EPV), % of EV
Market-Implied Value of Growth (MIVoG), % of EV
Reverse DCF (implied FCF growth)
Reverse DCF (implied Revenue growth)
$40.3B
$51.2B
$158.8
82.7% undervalued
N/A
$158.8
82.7% undervalued
$128.1
47.4% undervalued
$108.0
24.2% undervalued
N/A
N/A
0.0%
0.0%
$309.3B
$341.0B
$44.5
38.5% overvalued
$48.3
33.0% overvalued
$40.6
43.9% overvalued
$57.0
21.1% overvalued
$39.6
45.2% overvalued
40.8%
59.2%
13.8%
11.2%
$213.0B
$248.7B
$139.1
10.8% overvalued
$99.2
36.0% overvalued
$178.9
14.7% undervalued
$177.0
13.5% undervalued
$126.3
19.0% overvalued
65.5%
34.5%
4.7%
5.4%
$53.8B
$53.0B
$35.5
35.6% overvalued
$38.1
31.0% overvalued
$33.0
40.1% overvalued
$16.2
70.7% overvalued
$14.6
73.6% overvalued
43.6%
56.4%
7.1%
7.8%
$46.3B
$63.1B
$34.4
0.8% undervalued
$36.6
7.0% undervalued
$32.2
5.7% overvalued
$29.7
13.0% overvalued
$18.0
47.3% overvalued
58.3%
41.7%
1.5%
4.7%
$18.7B
$22.3B
$252.3
190.2% undervalued
$80.9
7.0% overvalued
$423.7
387.4% undervalued
$499.6
474.7% undervalued
$1,317.4
1,415.4% undervalued
6.5%
93.5%
50.5%
48.5%
$12.3B
$12.8B
$1,249.1
11.2% overvalued
$561.7
60.0% overvalued
$1,936.4
37.6% undervalued
Negative
496.4% overvalued
N/A
83.5%
16.5%
2.7%
2.8%
$6,270.1M
$5,400.1M
$16.1
37.3% overvalued
N/A
$16.1
37.3% overvalued
Negative
112.8% overvalued
$4.8
81.2% overvalued
19.7%
80.3%
19.6%
18.2%
$4,538.3M
$5,336.5M
$20.1
29.1% overvalued
$6.2
78.0% overvalued
$33.9
19.8% undervalued
Negative
143.8% overvalued
Negative
128.1% overvalued
37.4%
62.6%
(1.6%)
(1.9%)
$3,772.6M
$3,710.2M
$33.3
17.6% overvalued
$27.3
32.0% overvalued
$39.3
2.8% overvalued
$23.9
40.7% overvalued
$27.3
32.5% overvalued
53.7%
46.3%
6.2%
6.5%
$3,227.4M
$4,319.2M
$24.4K
120,518.9% undervalued
$8,433.0
41,524.0% undervalued
$40.4K
199,513.9% undervalued
$1,020.9K
5,038,988.0% undervalued
$12.2K
60,344.8% undervalued
110.2%
(10.2%)
(13.0%)
(2.1%)

Intrinsic Valuation Tools

Wondering how to calculate intrinsic value of a stock? Use our intrinsic value tools to simplify complex valuation concepts and save time.